Prolonged dual antiplatelet therapy with ticagrelor 60 mg twice daily in patients with a prior myocardial infarction: real-world insights on incidence and reasons for non-compliance
{{output}}
Background: Prolonged dual antiplatelet therapy (DAPT) with ticagrelor 60 mg is recommended in post-myocardial infarction (MI) patients at moderate to high ischemic risk. Beyond physician-led discontinuation, persistence with the... ...
